Link Pharma Chem Limited (BOM:524748)
India flag India · Delayed Price · Currency is INR
26.63
+1.13 (4.43%)
At close: Nov 16, 2026

Link Pharma Chem Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
274.23274.32254.33298.98387.58535.61
Other Revenue
0.37-----
274.6274.32254.33298.98387.58535.61
Revenue Growth
6.04%7.86%-14.93%-22.86%-27.64%53.85%
Cost of Revenue
116.41112.91128.97172.93221.75372.08
Gross Profit
158.2161.41125.37126.05165.83163.53
Selling, General & Admin
62.1560.8853.9255.1656.8957.82
Other Operating Expenses
80.9882.4870.1677.2377.8170.7
Operating Expenses
156.81156.36133.51142.89147.88137.79
Operating Income
1.395.05-8.14-16.8417.9525.74
Interest Expense
-5.57-5.3-7.76-8.72-7.61-4.51
Interest & Investment Income
0.380.380.620.641.131.18
Currency Exchange Gain (Loss)
0.040.040.010.04-0.44
Other Non Operating Income (Expenses)
0.310.310-0--
EBT Excluding Unusual Items
-3.460.47-15.27-24.8911.4722.85
Gain (Loss) on Sale of Investments
0.880.881.254.94-2.612.19
Gain (Loss) on Sale of Assets
---0.79-1.18
Pretax Income
-2.581.35-14.03-19.168.8626.22
Income Tax Expense
-0.130.58-3.75-5.532.327.4
Net Income
-2.450.77-10.27-13.636.5418.82
Net Income to Common
-2.450.77-10.27-13.636.5418.82
Net Income Growth
-----65.23%73.45%
Shares Outstanding (Basic)
444444
Shares Outstanding (Diluted)
444444
Shares Change
7.22%-----
EPS (Basic)
-0.550.17-2.31-3.071.474.24
EPS (Diluted)
-0.550.17-2.31-3.071.474.24
EPS Growth
-----65.23%73.45%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
14.540.4724.29-9.78-26-24.15
Free Cash Flow Per Share
3.240.105.47-2.20-5.86-5.44
Gross Margin
57.61%58.84%49.29%42.16%42.79%30.53%
Operating Margin
0.51%1.84%-3.20%-5.63%4.63%4.81%
Profit Margin
-0.89%0.28%-4.04%-4.56%1.69%3.51%
Free Cash Flow Margin
5.30%0.17%9.55%-3.27%-6.71%-4.51%
EBITDA
11.8714.851.29-6.527.1835.02
EBITDA Margin
4.32%5.41%0.51%-2.17%7.01%6.54%
D&A For EBITDA
10.499.89.4310.349.239.28
EBIT
1.395.05-8.14-16.8417.9525.74
EBIT Margin
0.51%1.84%-3.20%-5.63%4.63%4.81%
Effective Tax Rate
-43.08%--26.20%28.22%
Revenue as Reported
276.64276.35256.2305.38386.11540.25
Advertising Expenses
-----0.09